Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, Hildmann H, Ryan AF. Angio- genesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 2000;11:793-798.
Sudhoff H, Klenke C, Janowski S, Borck D, Widera D, Ebmeyer J, Kalinowski J, Leichtle A, Hofestädt R, Upile T, Kaltschmidt C, Kaltschmidt B. Identifi- cation of novel cholesteatoma-related gene expres- sion signatures using full-genome microarrays. De- partment of Otolaryngology and Head and Neck Surgery. Klinikum Bielefeld, Germany 2012;7:52-71.
Kanemaru Shin-ichi. Bone destructive mechanisms of cholesteatoma. The 9th International conference on cholesteatoma and ear surgery. Nagasaki, Japan. June 3-7 2012; 195.
Lim DJ, Li JD, Hermansson A, Ryan AF, Bakaletz LO, Brown SD, Cheeseman MT, Juhn SK, Jung TT, Lim JH, Lin J, Moon SK, Post JC. Recent advanc- es in otitis media in molecular biology, biochemis- try, genetics and animal models. Otolaryngol Head Neck Surg. 2013;5:52-63.
Offeciers E, Vercruysse JP, De Foer B, Somers T, Casselman J. Mastoid and epitympanic oblit- eration. The bone obliteration technique. B Ars Chronic Otitis Media. Pathogenesis-oriented ther- apeutic management. Amsterdam: Kugler Publica- tion; 2008. 299-327.
Sanna M, Sunose H, Mancini F, Russo A. Middle ear and mastoid microsurgery, Stuttgart-New York: Georg ThiemeVerlag; 2003.
Sade J. Surgical planning of the treatment of cho- lesteatoma and postoperative follow-up. Ann Otol Rhinol Laryngol. 2000;4: 372-376.
Mercke U. The cholesteatoma ear one year after surgery with obliteration technique. Am J Otol. 1987;6:534-536.
Kim M, Choi J. Hearing outcomes according to the types of mastoidectomy: a comparison between CWU and CWD mastoidectomy. Clinical and Ex- perimental Otorhinolaryngology. 2010;12:203-206.
Lee W, Kim S, Moon I, Byeon H. Canal wall recon- struction and mastoid obliteration in canal wall down tympanomastoidectomized patients. Ac- taotolaryngologica 2009;4:955-961.
Kim J, Choi J, Chung J. Clinical results of attico- antrotomy with attic reconstruction or attic oblit- eration for patients with an attic cholesteatoma. Clinical and Experimental Otorhinolaryngology. 2009;1:39-43.
S Kosyakov, V Korshok, E Pchelenok. Open tech- nique cholesteatoma surgery with obliteration of paratympanic spaces. The 9th International confer- ence on cholesteatoma and ear surgery; June. 3-7 2012; Japan, Nagasaki; 2012. 285.
Grantz BJ, Wilkinson EP, Hansen MR. Canal wall reconstruction tympanomastoidectomy with mas- toid obliteration. Laryngoscope 2005;3:1734-1740.
Yung MM, Karia KR. Mastoid obliteration with hy- droxyapatite-the value of high resolution CT scan- ning in detecting recurrent cholesteatoma. Clin Otolaryngol Allied Sci. 1997:6:553-557.
P. Aikele, T. Kittner, C. Offergeld. Diffusion- weighted MR imaging of cholesteatoma in pediat- ric and adult patients who have undergone middle ear surgery. AJR. 2003;2:261-265.
Vercruysse JP, De Foer B, Somers T, Casselman JW, Offeciers E. Mastoid and epitympanic bony oblit- eration in pediatric cholesteatoma. Otol Neurotol. 2008;7:953-960.
B De Foer, JPh Vercruysse, A. Bernaerts, F Deck- ers, T Somers, R Hermans, E Offeciers. Value of non-echo-planar diffusion-weighted magnetic res- onance imaging versus delayed post-gadolinium T1-weighted magnetic resonance imaging for the detection of middle ear cholesteatoma. Radiology. 2010;10:866-872.
Vercruysse JP, De Foer B, Somers T, Casselman J, Offeciers E. Long-term follow up after bony mas- toid and epitympanic obliteration: radiological findings. J Laryngol Otol. 20101:37-43.